Clinical Trials in San Diego

Showing 3761-3780 of 12,589 trials

Open-Label Study of Setmelanotide in Hypothalamic Obesity

NCT04725240

Open-label, single-arm study designed to evaluate the body weight response to setmelanotide administered subcutaneously (SC) daily in participants with hypothalamic obesity (HO).

Hypothalamic Obesity

Rhythm Pharmaceuticals, Inc.18 participantsStarted Jun 2021

San Diego, California, United States • Gainesville, Florida, United States • Saint Paul, Minnesota, United States +2 more locations

COMPLETEDNA< 1 mile

Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

NCT05971381

To evaluate repigmentation and quality of life after treatment of stable vitiligo lesions using the RECELL Device.

Vitiligo

Avita Medical109 participantsStarted Aug 2023

Scottsdale, Arizona, United States • Irvine, California, United States • San Diego, California, United States +14 more locations

Open-Label Study of Setmelanotide in Hypothalamic Obesity

Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

Find Trials by Condition in San Diego

Microbiome, Atopic Disease, Prematurity

A Phase 3 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Participants With PTSD

Different Doses of Naronapride Vs. Placebo in Gastroparesis

High Dose IL-2 in Combination With Anti-PD-1 to Overcome Anti-PD-1 Resistance in Metastatic Melanoma and Renal Cell Carcinoma

Single Center Exploratory Study To Evaluate The Use Of The RxSight Light Adjustable Lens (LAL) And The Light Delivery Device (LDD) To Improve Visual Outcomes

Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers

Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic Dermatitis

Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

DS-3201b in Participants With Lymphomas

Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements

This is a Study to Evaluate the Safety and Tolerability of ABL503, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL503 in Subjects with Any Progressive Locally Advanced or Metastatic Solid Tumors

Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy

A Study of SGN-ALPV in Advanced Solid Tumors

A Trial of a Novel XPO1 Inhibitor in Participants With Advanced Solid Tumors

A Study of the Safety and Tolerability in Participants With PIK3CA-related Overgrowth Spectrum or Proteus Syndrome Who Are Being Treated With Miransertib (MK-7075) in Other Studies (MK-7075-006)

LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and Crizotinib